Give | Events
Hope Is Real
December 10, 2014
Emily Whitehead, the first child to receive T-cell therapy, experienced something AMAZING. Two days after receiving this thearpy, THERE WAS NO LONGER ANY CANCER IN HER BODY.
Now the whole world wants to know if this T-cell therapy can produce the same kind of dramatic response in children with other types of aggressive cancers.
Novel Clinical Research Webinar for Families, Caregivers and Researchers
August 29, 2013
To help increase awareness about the latest developments in clinical research/trials for kids with neuroblastoma and other deadly childhood cancers, SKC held a webinar on Thursday, August 29, 2013 from 4:00PM - 4:30PM EST, entitled, "Immunotherapy for Neuroblastoma/Solid Tumors using a Child's Own Genetically modified T-cells "
This type of immunotherapy is at the vanguard of clinical cancer research and has demonstrated early dramatic results including complete responses in some adults and children with blood cancers. Researchers are now attempting to duplicate this success with pediatric solid tumors.
Dr. Chrystal Louis, Assistant Professor of Pediatrics - Hematology/Oncology at Baylor College of Medicine and Texas Children's Hospital presented an overview of this next-generation immunotherapy that is underway as a clinical trial at Baylor. Dr. Louis and her colleagues at Baylor/Texas Children's are among the leading investigators in the world in novel immunotherapy for childhood cancers.
View a recording of the webiner here.